Innovation in healthcare: opportunity + capability

Inbio ventures

Latest news

Proteon Therapeutics Goes Public on NASDAQ

read more →

Inbio Ventures Co-Leads Syndicated $45 Million Series D Investment in Proteon Therapeutics

read more →

Inbio Ventures Represents Lead Investor in $42.5 Million Financing Round for Argos Therapeutics

read more →